TrialPediatric blood & cancer2015

Tumoral TP53 and/or CDKN2A alterations are not reliable prognostic biomarkers in patients with localized Ewing sarcoma: a report from the Children's Oncology Group.

Daniel M Lerman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.